학술논문
Subgroup analyses of primary refractory (refr) vs early relapsed (rel) large B-cell lymphoma (LBCL) from the TRANSFORM study of lisocabtagene maraleucel (liso-cel) vs standard of care (SOC) as second-line (2L) therapy.
Document Type
Article
Author
Nastoupil, Loretta J.; Kamdar, Manali K.; Chavez, Julio C.; Ghesquieres, Herve; Ghosh, Monalisa; Holmes, Houston; López Guillermo, Armando; Martinez-Lopez, Joaquin; Novak, Urban; Ribrag, Vincent; Roddie, Claire; Waller, Edmund K.; Feldman, Tatyana A; Rosenthal, Allison Claire; Sauter, Craig; Von Bonin, Malte; Karmali, Reem; Montheard, Sandrine; Previtali, Alessandro; Abramson, Jeremy S.
Source
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p7526-7526, 1p
Subject
Language
ISSN
0732183X